Targeting for Prevention: The Logic of Funding an Ambitious Health Data Project https://t.co/hjftCVO3nG…
Pharmaceutical promotion to physicians is designed to drive brand positioning which in turn drives brand treatment choice (‘pen-to-paper’) as represented below. Promotional effectiveness along the physician treatment choice pathway has historically been poorly understood in Oncology markets due to a lack of robust integrated promotion and treatment data. Consequently efforts at resource allocation in these markets are rarely informed by robust, well-specified promotional response models. This presentation addresses this unmet need.
Click to view this ‘PMSA Poster‘ from our Commercial Effectiveness Consulting group.
We’ve made it easy to share this story with colleagues, friends or your favorite social media websites.